| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $930.0M | $787.2M | $670.6M |
| YoY Revenue Growth % | +18.1% | +17.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $255.9M | $228.2M | $150.8M |
| Operating Margin % | 27.5% | 29.0% | 22.5% |
| Net Income (GAAP) | $140.3M | $118.6M | $87.2M |
| EBITDA (Normalized) | $614.8M | $512.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $233.7M | $239.4M | $203.5M |
| Capital Expenditures (CapEx) | $448.6M | $355.3M | — |
| Free Cash Flow (FCF) | -$214.9M | -$115.9M | $203.5M |
| FCF Margin % | -23.1% | -14.7% | 30.3% |
| Return on Invested Capital (ROIC %) | 6.9% | 6.8% | — |
| Cash & Short-Term Equivalents | $1.8M | $7.9M | — |
| Total Debt (Short + Long Term) | $1.33B | $1.26B | — |
| Total Stockholders' Equity | $1.60B | $1.39B | — |